StockWatch: Pfizer Sales Jump on Rival’s Errors
Pfizer appears to be in the driver's seat in the global Covid-19 vaccine market. Their jab has demonstrated high efficacy and their sales have jumped up to $1.4 Billion.
J&J reported $100 million in first-quarter sales of its…
Read More
Read More